Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations

Antimicrob Agents Chemother. 2013 Jun;57(6):2882-6. doi: 10.1128/AAC.00261-13. Epub 2013 Apr 9.

Abstract

Due to the ongoing problem of recurrence of Clostridium difficile-associated diarrhea following antibiotic treatment, there is an urgent need for alternative treatment options. We assessed the MICs of five antimicrobials singly and in combinations against a range of C. difficile clinical isolates. Ramoplanin-actagardine combinations were particularly effective, with partial synergistic/additive effects observed against 61.5% of C. difficile strains tested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacteriocins / pharmacology*
  • Bacteriocins / therapeutic use
  • Clostridioides difficile / drug effects*
  • Clostridioides difficile / isolation & purification
  • Depsipeptides / pharmacology*
  • Depsipeptides / therapeutic use
  • Drug Synergism
  • Drug Therapy, Combination
  • Enterocolitis, Pseudomembranous / drug therapy
  • Enterocolitis, Pseudomembranous / microbiology*
  • Humans
  • Metronidazole / pharmacology
  • Metronidazole / therapeutic use
  • Microbial Sensitivity Tests / standards
  • Peptides / pharmacology*
  • Peptides / therapeutic use
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Bacteriocins
  • Depsipeptides
  • Peptides
  • ramoplanin
  • Metronidazole
  • thuricin
  • gardimycin
  • Vancomycin